{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:51:43Z","timestamp":1648655503343},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.mehy.2005.11.026","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:06:46Z","timestamp":1137697606000},"page":"1046-1047","source":"Crossref","is-referenced-by-count":0,"title":["Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt\u2019s lymphoma tumorigenesis can be enhanced"],"prefix":"10.1016","volume":"66","author":[{"given":"Alan","family":"Wiseman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2005.11.026_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mehy.2005.01.041","article-title":"P-53 protein is activated by Pin-1: and also by Cu-SOD prion-like enzyme","volume":"65","author":"Wiseman","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2005.11.026_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p-53 tumour surveillance network by tumour-derived MYC mutants","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2005.11.026_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature03991","article-title":"Evolutionary information for specifying a protein fold","volume":"437","author":"Socolich","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mehy.2005.11.026_bib4","first-page":"24","article-title":"Oxaliplatin and targeted adjunct chemotherapy for bowel cancer through DNA binding: causal involvement of ROS","volume":"5","author":"Wiseman","year":"2005","journal-title":"J Appl Therapeutic Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705006237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705006237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:25:56Z","timestamp":1547868356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705006237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0306987705006237"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2005.11.026","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}